Food Allergy Safety, Treatment, Education, and Research Act of 2020

Bill: 116-hr-2117
Sponsor: full_name: Rep. Matsui, Doris O. [D-CA-6]
Introduced: 2019-04-08
Policy area: Health
Subjects: Allergies

Congressional oversight

Food supply, safety, and labeling

Government studies and investigations

Health information and medical records
Latest action: action_date: 2020-11-18
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2019-04-08
action_desc: Introduced in House
text: <p><b>Food Allergy Safety, Treatment, Education, and Research Act of 2019 or the FASTER Act of 2019</b></p> <p>This bill directs the Centers for Disease Control and Prevention to expand data collection of information related to&nbsp;food allergies and specific allergens and revises the definition of <em>major allergen</em> to specifically include sesame. The Department of Health and Human Services may designate additional food ingredients as major allergens based on the prevalence and severity of allergic reactions through regulation.</p> <p>The Food and Drug Administration and the National Institutes of Health must report on specified information regarding food allergies.</p>  <p> <br /></p>

action_date: 2020-11-16
action_desc: Reported to House
text: <p><b>Food Allergy Safety, Treatment, Education, and Research Act of 2020 or the FASTER Act of 2020</b></p> <p>This bill directs the Centers for Disease Control and Prevention to expand data collection of information related to&nbsp;food allergies and specific allergens and revises the definition of <em>major allergen</em> to specifically include sesame. The Department of Health and Human Services may designate additional food ingredients as major allergens based on the prevalence and severity of allergic reactions through regulation.</p> <p>The Food and Drug Administration must report on specified information regarding food allergies.</p> <p> <br /></p>

action_date: 2020-11-17
action_desc: Passed House
text: <p><b>Food Allergy Safety, Treatment, Education, and Research Act of 2020 or the FASTER Act of 2020</b></p> <p>This bill directs the Centers for Disease Control and Prevention to expand data collection of information related to&nbsp;food allergies and specific allergens and revises the definition of <em>major allergen</em> to specifically include sesame. The Department of Health and Human Services may designate additional food ingredients as major allergens based on the prevalence and severity of allergic reactions through regulation.</p> <p>The Food and Drug Administration must report on specified information regarding food allergies.</p> <p> <br /></p>

tv_txt: I 116th CONGRESS 1st Session H. R. 2117 IN THE HOUSE OF REPRESENTATIVES April 8, 2019 Ms. Matsui introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To improve the health and safety of Americans living with food allergies and related disorders, including potentially life-threatening anaphylaxis, food protein-induced enterocolitis syndrome, and eosinophilic gastrointestinal diseases, and for other purposes.

1. Short title This Act may be cited as the Food Allergy Safety, Treatment, Education, and Research Act of 2019 or the FASTER Act of 2019 . 2. Food allergy safety recommendations of the National Academy of Medicine (a) Collection of food allergy data The Public Health Service Act is amended by inserting after section 317T of such Act ( 42 U.S.C. 247b–22 ) the following new section: 317U. Collection of food allergy data The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall— (1) expand and intensify the collection of information on the prevalence of food allergies for specific allergens in the United States, such as through the National Health and Nutrition Examination Survey; and (2) include such information within annual or other periodic reporting to the Congress and the public on other surveillance activities. . (b) Allergen labeling (1) Major allergen definition Section 201(qq)(1) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 3211(qq)(1) ) is amended by striking and soybeans and inserting soybeans, and sesame . (2) Additional allergens Section 201(qq) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 3211(qq)(1) ) is amended by adding at the end the following: (3) Any other food ingredient that the Secretary determines by regulation to be a major food allergen, based on the prevalence and severity of allergic reactions to the food ingredient. . 3. Report on use by FDA of patient experience data on treatments for patients with food allergies Section 3004 of the 21st Century Cures Act ( 21 U.S.C. 355 note) is amended— (1) by striking Not later than and inserting the following: (a) In general Not later than ; and (2) by adding at the end the following: (b) Treatments for patients with food allergies Each report under subsection (a) shall include a synopsis of the use by the Food and Drug Administration in regulatory decisionmaking of patient experience data on treatments for patients with food allergies. . 4. Study on economic costs of food allergies The Director of the National Institutes of Health shall seek to enter into an arrangement with the National Academies of Sciences, Engineering, and Medicine (or if the National Academies decline to enter into an arrangement, another appropriate entity) to— (1) study the economic costs of food allergies in the United States, both individually and for the food allergy population overall; and (2) not later than 1 year after the date of enactment of this Act— (A) complete such study; (B) submit to the Congress a report on the results of such study; and (C) publish such report.

tv_txt: I 116th CONGRESS 2d Session H. R. 2117 IN THE HOUSE OF REPRESENTATIVES AN ACT To improve the health and safety of Americans living with food allergies and related disorders, including potentially life-threatening anaphylaxis, food protein-induced enterocolitis syndrome, and eosinophilic gastrointestinal diseases, and for other purposes.

1. Short title This Act may be cited as the Food Allergy Safety, Treatment, Education, and Research Act of 2020 or the FASTER Act of 2020 . 2. Food allergy safety recommendations of the National Academy of Medicine (a) Collection of food allergy data The Public Health Service Act is amended by inserting before section 318 of such Act ( 42 U.S.C. 247c ) the following new section: 317W. Collection of food allergy data (a) In general The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall— (1) expand and intensify the collection of information on the prevalence of food allergies for specific allergens in the United States, such as through the National Health and Nutrition Examination Survey and the National Health Interview Survey; (2) include such information within annual or other periodic reporting to the Congress and the public on other surveillance activities; and (3) encourage research to improve the accuracy of food allergy prevalence data. (b) Biomarkers Any research conducted pursuant to subsection (a)(3) shall include— (1) the identification of biomarkers and tests to validate data generated from such research; and (2) the investigation of the use of identified biomarkers and tests in national surveys conducted as part of that research. . (b) Allergen labeling (1) Major food allergen definition (A) In general Section 201(qq)(1) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(qq)(1) ) is amended by striking and soybeans and inserting soybeans, and sesame . (B) Effective date The amendment made by subparagraph (A) shall apply with respect to food introduced or delivered for introduction into interstate commerce on or after January 1, 2022. (2) Additional allergens Section 201(qq) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(qq) ) is amended by adding at the end the following: (3) Any other food ingredient that the Secretary determines by regulation to be a major food allergen, based on the scientific criteria determined by the Secretary (including the prevalence and severity of allergic reactions to the food ingredient) that establish that such food ingredient is an allergen of public health concern. . (3) Technical corrections Section 201(qq)(2) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(qq)(2) ) is amended by striking paragraph each place it appears and inserting subparagraph . 3. Report on use by FDA of patient experience data on treatments for patients with food allergies Section 3004 of the 21st Century Cures Act ( 21 U.S.C. 355 note) is amended— (1) by striking Not later than and inserting the following: (a) In general Not later than ; and (2) by adding at the end the following: (b) Treatments for patients with food allergies Each report under subsection (a) shall include a synopsis of the use by the Food and Drug Administration in regulatory decisionmaking of patient experience data on products with an indication for the treatment of a food allergy. .

Passed the House of Representatives November 17, 2020. Cheryl L. Johnson, Clerk.

tv_txt: IIB 116th CONGRESS 2d Session H. R. 2117 IN THE SENATE OF THE UNITED STATES November 18, 2020 Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions AN ACT To improve the health and safety of Americans living with food allergies and related disorders, including potentially life-threatening anaphylaxis, food protein-induced enterocolitis syndrome, and eosinophilic gastrointestinal diseases, and for other purposes.

1. Short title This Act may be cited as the Food Allergy Safety, Treatment, Education, and Research Act of 2020 or the FASTER Act of 2020 . 2. Food allergy safety recommendations of the National Academy of Medicine (a) Collection of food allergy data The Public Health Service Act is amended by inserting before section 318 of such Act ( 42 U.S.C. 247c ) the following new section: 317W. Collection of food allergy data (a) In general The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall— (1) expand and intensify the collection of information on the prevalence of food allergies for specific allergens in the United States, such as through the National Health and Nutrition Examination Survey and the National Health Interview Survey; (2) include such information within annual or other periodic reporting to the Congress and the public on other surveillance activities; and (3) encourage research to improve the accuracy of food allergy prevalence data. (b) Biomarkers Any research conducted pursuant to subsection (a)(3) shall include— (1) the identification of biomarkers and tests to validate data generated from such research; and (2) the investigation of the use of identified biomarkers and tests in national surveys conducted as part of that research. . (b) Allergen labeling (1) Major food allergen definition (A) In general Section 201(qq)(1) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(qq)(1) ) is amended by striking and soybeans and inserting soybeans, and sesame . (B) Effective date The amendment made by subparagraph (A) shall apply with respect to food introduced or delivered for introduction into interstate commerce on or after January 1, 2022. (2) Additional allergens Section 201(qq) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(qq) ) is amended by adding at the end the following: (3) Any other food ingredient that the Secretary determines by regulation to be a major food allergen, based on the scientific criteria determined by the Secretary (including the prevalence and severity of allergic reactions to the food ingredient) that establish that such food ingredient is an allergen of public health concern. . (3) Technical corrections Section 201(qq)(2) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(qq)(2) ) is amended by striking paragraph each place it appears and inserting subparagraph . 3. Report on use by FDA of patient experience data on treatments for patients with food allergies Section 3004 of the 21st Century Cures Act ( 21 U.S.C. 355 note) is amended— (1) by striking Not later than and inserting the following: (a) In general Not later than ; and (2) by adding at the end the following: (b) Treatments for patients with food allergies Each report under subsection (a) shall include a synopsis of the use by the Food and Drug Administration in regulatory decisionmaking of patient experience data on products with an indication for the treatment of a food allergy. .

Passed the House of Representatives November 17, 2020. Cheryl L. Johnson, Clerk.

tv_txt: IB Union Calendar No. 479 116th CONGRESS 2d Session H. R. 2117 [Report No. 116–581] IN THE HOUSE OF REPRESENTATIVES April 8, 2019 Ms. Matsui introduced the following bill; which was referred to the Committee on Energy and Commerce November 16, 2020 Additional sponsors: Mr. Rose of New York , Mrs. Murphy of Florida , Mr. McHenry , Miss Rice of New York , Ms. Kuster of New Hampshire , Mr. Khanna , Mr. Connolly , Mr. Cooper , Mr. Gottheimer , Mr. Burchett , Ms. Pingree , Mr. Raskin , Mr. Ryan , Mr. Fitzpatrick , Ms. Barragán , Mr. Levin of California , Mr. Katko , Mrs. Luria , Ms. Sherrill , Mr. Suozzi , Mr. Van Drew , Ms. Wild , Mr. Stivers , Mr. Lamb , Mr. Harder of California , Ms. Schakowsky , Mr. Brendan F. Boyle of Pennsylvania , Mr. Cline , Mr. Brindisi , Ms. Stefanik , Mr. Himes , Ms. Dean , Ms. Blunt Rochester , Mr. McGovern , Mr. Cunningham , Mr. Joyce of Ohio , Mr. Upton , Mrs. Dingell , Mr. Pocan , Mr. Cox of California , Ms. Spanberger , Mrs. Axne , Mr. Steil , Mrs. Kirkpatrick , Mr. Perlmutter , Ms. Jackson Lee , Mr. Neguse , Mr. Lipinski , Mr. Malinowski , Mrs. Hayes , Ms. Velázquez , Mr. Gallagher , Mr. Reed , Mr. Peters , Mr. Carbajal , Mr. O'Halleran , Mr. Nadler , Ms. Torres Small of New Mexico , Mr. McAdams , Ms. Stevens , Mrs. Carolyn B. Maloney of New York , Mr. Schneider , Mr. Norcross , Mr. Cisneros , Ms. Norton , Mr. Delgado , Mr. Panetta , Mr. Riggleman , Mr. Stauber , Mr. Langevin , Mr. Amodei , Mr. Johnson of South Dakota , Mr. Johnson of Ohio , Mr. Casten of Illinois , Mr. Bacon , Mrs. Trahan , Mr. Keating , Ms. Jayapal , Mr. Sean Patrick Maloney of New York , Mr. Horsford , Mrs. Brooks of Indiana , Mr. Mitchell , Mr. Meuser , Mr. Gonzalez of Ohio , Mr. Hurd of Texas , Mr. Thompson of Pennsylvania , Mr. Wittman , Mr. Levin of Michigan , Mr. Cicilline , Ms. Brownley of California , Mr. Pappas , Mr. Vargas , and Mr. Taylor November 16, 2020 Reported with an amendment; committed to the Committee of the Whole House on the State of the Union and ordered to be printed Strike out all after the enacting clause and insert the part printed in italic For text of introduced bill, see copy of bill as introduced on April 8, 2019 A BILL To improve the health and safety of Americans living with food allergies and related disorders, including potentially life-threatening anaphylaxis, food protein-induced enterocolitis syndrome, and eosinophilic gastrointestinal diseases, and for other purposes.

1. Short title This Act may be cited as the Food Allergy Safety, Treatment, Education, and Research Act of 2020 or the FASTER Act of 2020 . 2. Food allergy safety recommendations of the National Academy of Medicine (a) Collection of food allergy data The Public Health Service Act is amended by inserting before section 318 of such Act ( 42 U.S.C. 247c ) the following new section: 317W. Collection of food allergy data (a) In general The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall— (1) expand and intensify the collection of information on the prevalence of food allergies for specific allergens in the United States, such as through the National Health and Nutrition Examination Survey and the National Health Interview Survey; (2) include such information within annual or other periodic reporting to the Congress and the public on other surveillance activities; and (3) encourage research to improve the accuracy of food allergy prevalence data. (b) Biomarkers Any research conducted pursuant to subsection (a)(3) shall include— (1) the identification of biomarkers and tests to validate data generated from such research; and (2) the investigation of the use of identified biomarkers and tests in national surveys conducted as part of that research. . (b) Allergen labeling (1) Major food allergen definition (A) In general Section 201(qq)(1) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(qq)(1) ) is amended by striking and soybeans and inserting soybeans, and sesame . (B) Effective date The amendment made by subparagraph (A) shall apply with respect to food introduced or delivered for introduction into interstate commerce on or after January 1, 2022. (2) Additional allergens Section 201(qq) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(qq) ) is amended by adding at the end the following: (3) Any other food ingredient that the Secretary determines by regulation to be a major food allergen, based on the scientific criteria determined by the Secretary (including the prevalence and severity of allergic reactions to the food ingredient) that establish that such food ingredient is an allergen of public health concern. . (3) Technical corrections Section 201(qq)(2) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(qq)(2) ) is amended by striking paragraph each place it appears and inserting subparagraph . 3. Report on use by FDA of patient experience data on treatments for patients with food allergies Section 3004 of the 21st Century Cures Act ( 21 U.S.C. 355 note) is amended— (1) by striking Not later than and inserting the following: (a) In general Not later than ; and (2) by adding at the end the following: (b) Treatments for patients with food allergies Each report under subsection (a) shall include a synopsis of the use by the Food and Drug Administration in regulatory decisionmaking of patient experience data on products with an indication for the treatment of a food allergy. .

November 16, 2020 Reported with an amendment; committed to the Committee of the Whole House on the State of the Union and ordered to be printed